Should cetuximab replace Cisplatin for definitive chemoradiotherapy in locally advanced head and neck cancer?

J Clin Oncol. 2013 Jan 10;31(2):287-8. doi: 10.1200/JCO.2012.46.9049. Epub 2012 Dec 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Cetuximab
  • Chemoradiotherapy
  • Cisplatin / adverse effects
  • Cisplatin / therapeutic use*
  • Head and Neck Neoplasms / drug therapy*
  • Head and Neck Neoplasms / pathology
  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Retrospective Studies

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Cetuximab
  • Cisplatin